Improving heart disease risk predictions for Hispanics and Latinos
Toward Accurate Cardiovascular Disease Prediction in Hispanics/Latinos: Modeling Risk and Resilience Factors
This study is looking to improve how we predict the risk of heart disease for Hispanics and Latinos, so that the information is more accurate and helpful for their health needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10876392 on NIH RePORTER |
What this research studies
This research aims to enhance the accuracy of cardiovascular disease (CVD) risk predictions specifically for Hispanics and Latinos, who are often misrepresented in existing models. By analyzing secondary data, the project will identify unique risk and resilience factors that affect this population, which are often overlooked in traditional models. The approach combines theoretical frameworks with data-driven methods to refine current 10-year CVD risk models, ensuring they are more representative and applicable to Hispanics and Latinos. This work is expected to lead to better-targeted interventions and improved health outcomes for this community.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanics and Latinos who are at risk for cardiovascular diseases.
Not a fit: Patients who do not identify as Hispanic or Latino may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate heart disease risk assessments for Hispanics and Latinos, ultimately improving prevention and treatment strategies.
How similar studies have performed: Previous research has shown that tailored risk models can significantly improve health outcomes in underrepresented populations, suggesting this approach has potential for success.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Flores, Melissa Ann — University of Arizona
- Study coordinator: Flores, Melissa Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.